Organization Overview
Alternative names
acalabrutinib (calquence) (2 trials)
autologous hematopoietic stem cells (1 trial)
bendamustine (treanda) (3 trials)
bleomycin (blenoxane) (9 trials)
brentuximab vedotin (adcetris) (4 trials)
bupropion (wellbutrin) (1 trial)
chlorambucil (Leukeran) (1 trial)
cisplatin (platinol) (2 trials)
cyclophosphamide (cytoxan) (22 trials)
cytarabine (cytosar-u) (1 trial)
docetaxel (taxotere) (2 trials)
doxorubicin (Doxil) (16 trials)
enoxaparin (lovenox) (1 trial)
epirubicin (ellence) (2 trials)
etoposide (vepesid) (10 trials)
fludarabine (fludara) (11 trials)
fluorouracil (efudex) (3 trials)
fosfomycin (monurol) (1 trial)
gentamicin (garamycin) (1 trial)
ibrutinib (imbruvica) (2 trials)
isavuconazonium (cresemba) (1 trial)
mesalamine (rowasa) (2 trials)
mitoxantrone (novantrone) (2 trials)
moxifloxacin (avelox) (1 trial)
obinutuzumab (gazyva) (3 trials)
oxcarbazepine (trileptal) (1 trial)
prednisone (meticorten) (9 trials)
procarbazine (matulane) (9 trials)
remifentanil (ultiva) (1 trial)
albumin (Human) (Plasbumin) (1 trial)
aldesleukin (Proleukin) (1 trial)
alectinib (alecensa) (1 trial)
alemtuzumab (campath) (3 trials)
amphotericin b (fungizone) (1 trial)
anti-cd19/20-car vector-transduced t cells (2 trials)
bevacizumab (avastin) (3 trials)
bnt162b2 (Comirnaty) (1 trial)
bortezomib (velcade) (1 trial)
bromocriptine (parlodel) (1 trial)
cannabidiol (Epidiolex) (4 trials)
celecoxib (celebrex) (1 trial)
crizotinib (xalkori) (1 trial)
daratumumab (darzalex) (1 trial)
dinutuximab (unituxin) (1 trial)
dobutamine (dobutrex) (1 trial)
dupilumab (dupixent) (1 trial)
durvalumab (imfinzi) (1 trial)
erdafitinib (Balversa) (1 trial)
erlotinib (tarceva) (2 trials)
everolimus (zortress) (4 trials)
fetal liver-derived mesenchymal stem cells (1 trial)
fluconazole (diflucan) (1 trial)
gemcitabine (gemzar) (4 trials)
immune globulin (human) (Gamastan) (1 trial)
ipilimumab (yervoy) (2 trials)
irinotecan (Camptosar) (1 trial)
lenalidomide (revlimid) (2 trials)
metronidazole (flagyl) (1 trial)
motexafin gadolinium (1 trial)
mrna-1273 (Spikevax) (1 trial)
ofatumumab (arzerra) (2 trials)
polatuzumab vedotin (Polivy) (1 trial)
posaconazole (noxafil) (1 trial)
prednisolone (hydeltra) (1 trial)
propranolol (inderal) (1 trial)
romidepsin (istodax) (2 trials)
ruxolitinib (jakafi) (1 trial)
sars-cov-2 specific t cells (1 trial)
solifenacin (vesicare) (2 trials)
tafasitamab (Monjuvi) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 3)
Acute Coronary Syndrome (Phase 3)
Acute Kidney Injury (Phase 3)
Adenocarcinoma (Phase 2)
Alzheimer Disease (Phase 3)
Anemia, Hemolytic (Phase 2)
Anemia, Hemolytic, Autoimmune (Phase 2)
Angina, Unstable (Phase 3)
Aspergillosis (Phase 2)
Bacteremia (Phase 3)
Breast Neoplasms (Phase 3)
Bronchial Neoplasms (Phase 1)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Small Cell (Phase 2)
Colorectal Neoplasms (Phase 2)
Conjunctivitis (Phase 2)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 4)
Coronavirus Infections (Phase 2)
Dementia (Phase 3)
Diabetes Mellitus (Phase 2)
Diabetic Retinopathy (Phase 4)
Dissociative Disorders (Phase 3)
Diverticular Diseases (Phase 2)
Diverticulosis, Colonic (Phase 2)
Diverticulum (Phase 2)
Dyspnea (Phase 2)
Dyspnea, Paroxysmal (Phase 2)
Enuresis (Phase 2)
Esophageal Neoplasms (Phase 2)
Glaucoma (Phase 3)
Glaucoma, Neovascular (Phase 3)
Graft vs Host Disease (Phase 2)
HIV Infections (Phase 3)
Hodgkin Disease (Phase 3)
Hyperoxaluria, Primary (Phase 2)
Hypertension (Phase 1)
Hypertriglyceridemia (Phase 3)
Immunologic Deficiency Syndromes (Phase 3)
Infections (Phase 2)
Intraabdominal Infections (Phase 2)
Invasive Pulmonary Aspergillosis (Phase 2)
Ischemia (Phase 3)
Kidney Diseases (Phase 3)
Kidney Failure, Chronic (Phase 3)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Prolymphocytic (Phase 2)
Leukemia, Prolymphocytic, T-Cell (Phase 2)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 1)
Lymphoma, T-Cell, Cutaneous (Phase 1)
Macular Degeneration (Phase 4)
Melanoma (Phase 3)
Mental Disorders (Phase 4)
Multiple Myeloma (Phase 3)
Mycoses (Phase 1)
Mycosis Fungoides (Phase 1)
Myocardial Ischemia (Phase 4)
Neoplasms (Phase 1)
Neoplasms, Plasma Cell (Phase 2)
Nephrocalcinosis (Phase 3)
Neuroblastoma (Phase 3)
Neutropenia (Phase 1)
Osteogenesis Imperfecta (Phase 2)
Pancreatic Neoplasms (Phase 1)
Prodromal Symptoms (Phase 4)
Psychotic Disorders (Phase 4)
Pulmonary Aspergillosis (Phase 2)
Raynaud Disease (Phase 3)
Renal Insufficiency (Phase 1)
Renal Insufficiency, Chronic (Phase 1)
Retinal Detachment (Phase 3)
Retinal Diseases (Phase 4)
Retinal Vein Occlusion (Phase 3)
Schizophrenia (Phase 4)
Scleroderma, Diffuse (Phase 2)
Scleroderma, Localized (Phase 2)
Scleroderma, Systemic (Phase 2)
Severe Acute Respiratory Syndrome (Phase 2)
Shock (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Syndrome (Phase 3)
Tachypnea (Phase 2)
Thrombosis (Phase 4)
Transient Tachypnea of the Newborn (Phase 2)
Tuberculosis (Phase 3)
Tuberculosis, Pulmonary (Phase 3)
Urinary Incontinence (Phase 2)
Urinary Incontinence, Urge (Phase 2)
Uveal Neoplasms (Phase 3)
Vitreoretinopathy, Proliferative (Phase 3)
Wounds and Injuries (Phase 3)